Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Science Board reviews CFSAN

This article was originally published in The Tan Sheet

Executive Summary

A subcommittee of the FDA advisory panel will review the science priorities, management oversight and infrastructure quality of the Center for Food Safety and Applied Nutrition, with the goal of issuing a final report in February 2010. Members of the FDA Science Board who volunteered for the subcommittee during an Aug. 17 meeting in Rockville, Md., were Rhona Applebaum, VP and chief scientific and regulatory officer for the Coca-Cola Co.; John Floros, professor of food science at Penn State University; and Larry Sasich, assistant professor of pharmacy practice at the Lake Erie College of Medicine. FDA is on a five-year cycle for reviewing intramural research in each of its centers, with the Center for Drug Evaluation and Research slated for review in 2010

You may also be interested in...



Chart: Science Board Makes Recommendations To CFSAN

Recent And Upcoming FDA Advisory Committee Meetings

Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.

International Harmonization: Not Just For Audits Anymore

The International Medical Device Regulators Forum, perhaps most notorious for its efforts to standardize audit processes between nations with its Medical Device Single Audit Program, is also focusing on harmonizing device reviews and adverse event codes.

UsernamePublicRestriction

Register

LL1133951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel